Comparison between Goldline Pharmaceutical IPO and K.V.Toys India IPO.
Goldline Pharmaceutical IPO is a SME Bookbuilding IPO proposed to list at BSE SME while K.V.Toys India IPO is a SME Bookbuilding proposed to list at BSE SME.
| Goldline Pharmaceutical IPO | K.V.Toys India IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Cumulative Capital Pvt.Ltd. | GYR Capital Advisors Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Purva Sharegistry (India) Pvt.Ltd. |
| Market Maker | Giriraj Stock Broking Pvt.Ltd. | |
| DRHP | DRHP  | DRHP |
| RHP | RHP | |
| Final Prospectus | Final Prospectus | |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Goldline Pharmaceutical IPO is up to ₹0.00 Cr whereas the issue size of the K.V.Toys India IPO is up to ₹37.74 Cr. The final issue price of Goldline Pharmaceutical IPO is and of K.V.Toys India IPO is ₹239.00 per share.
| Goldline Pharmaceutical IPO | K.V.Toys India IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹227.00 per share | |
| Issue Price (Upper) | ₹239.00 per share | |
| Issue Price (Final) | ₹239.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 600 shares | |
| Fresh Issue Size | 30,00,000 shares | 15,79,200 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹37.74 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 30,00,000 shares | 15,79,200 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹37.74 Cr |
Goldline Pharmaceutical IPO opens on , while K.V.Toys India IPO opens on Dec 08, 2025. The closing date of Goldline Pharmaceutical IPO and K.V.Toys India IPO is , and Dec 10, 2025, respectively.
| Goldline Pharmaceutical IPO | K.V.Toys India IPO | |
|---|---|---|
| Anchor Bid Date | Dec 05, 2025 | |
| Issue Open | Dec 08, 2025 | |
| Issue Close | Dec 10, 2025 | |
| Basis Of Allotment (Tentative) | Dec 11, 2025 | |
| Initiation of Refunds (Tentative) | Dec 12, 2025 | |
| Credit of Share (Tentative) | Dec 12, 2025 | |
| Listing date (Tentative) | Dec 15, 2025 | |
| Anchor Lockin End date 1 | Jan 12, 2026 | |
| Anchor Lockin End date 2 | Mar 13, 2026 |
Goldline Pharmaceutical IPO P/E ratio is , as compared to K.V.Toys India IPO P/E ratio of 23.94.
| Goldline Pharmaceutical IPO | K.V.Toys India IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Goldline Pharmaceutical Ltd.'s revenue increased by 19% and profit after tax (PAT) rose by 57% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 79.70 | 79.65 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 58.35 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 23.94 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹150.09 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 35.84 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 38.46 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.50 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹9.98 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 27.38 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Goldline Pharmaceutical IPO Retail Individual Investors (RII) are offered 0 shares while in K.V.Toys India IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Goldline Pharmaceutical IPO and 3,12,600 shares in K.V.Toys India IPO.
| Goldline Pharmaceutical IPO | K.V.Toys India IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 4,68,000 shares |
| Market Maker Reservation | 0 shares | 1,00,800 shares |
| QIB | 0 shares | 3,12,600 shares |
| NII | 0 shares | 2,39,400 shares |
| RII | 0 shares | 5,59,200 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 15,79,200 shares |
Goldline Pharmaceutical IPO subscribed in total, whereas K.V.Toys India IPO subscribed 248.12x.
| Goldline Pharmaceutical IPO | K.V.Toys India IPO | |
|---|---|---|
| QIB (times) | 193.25x | |
| NII (times) | 505.19x | |
| Big NII (times) | 577.76x | |
| Small NII (times) | 360.05x | |
| RII (times) | 376.41x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 248.12x |
